[Tyr0] Gastric Inhibitory Peptide (23-42), human

Modify Date: 2024-01-17 15:12:05

[Tyr0] Gastric Inhibitory Peptide (23-42), human structure	Common Name	[Tyr0] Gastric Inhibitory Peptide (23-42), human
	CAS Number	121765-67-1	Molecular Weight	2584.93
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₁₉H₁₈₂N₃₄O₃₁	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of [Tyr0] Gastric Inhibitory Peptide (23-42), human

[Tyr0] Gastric Inhibitory Peptide (23-42), human, a glucose-dependent insulinotropic polypeptide (GIP), is a weak inhibitor of gastric acid secretion that also stimulates insulin secretion. [Tyr0] Gastric Inhibitory Peptide (23-42), human can be used in diabetes, obesity research[1][2].

Name	[Tyr0] Gastric Inhibitory Peptide (23-42), human

Description	[Tyr0] Gastric Inhibitory Peptide (23-42), human, a glucose-dependent insulinotropic polypeptide (GIP), is a weak inhibitor of gastric acid secretion that also stimulates insulin secretion. [Tyr0] Gastric Inhibitory Peptide (23-42), human can be used in diabetes, obesity research[1][2].
Related Catalog	Research Areas >> Metabolic Disease Signaling Pathways >> Protein Tyrosine Kinase/RTK >> Insulin Receptor
In Vivo	GIPR-/- mice have higher blood glucose levels and impaired initial insulin response after oral glucose loading. In GIPR+/+ mice, a high-fat diet did not increase postprandial intake blood glucose levels, whereas it significantly increased in GIPR-/- mice[2].

Molecular Formula	C₁₁₉H₁₈₂N₃₄O₃₁
Molecular Weight	2584.93

[Tyr0] Gastric Inhibitory Peptide (23-42), human

Use of [Tyr0] Gastric Inhibitory Peptide (23-42), human

Names

Biological Activity

Chemical & Physical Properties